NDC codes

401334 NDC codes with hospital pricing data in the network.

• NDC 50881-0010-60 — Jakafi (33 hospitals, 3,192–3,255 samples)
• NDC 50881-0005-60 — ruxolitinib 5 mg tab (33 hospitals, 3,192–3,255 samples)
• NDC 00078-0526-87 — NILOTINIB HCL 200 MG ORAL CAP (15 hospitals, 3,192–3,255 samples)
• NDC 409475901 — ONDANSETRON HCL 40 MG/20ML IJ SOLN (95 hospitals, 2,902–3,253 samples)
• NDC 00641605610 — MIDAZOLAM 1 MG/ML (COMBINED) INJECTION SOLUTION WRAPPER (59 hospitals, 1,561–3,253 samples)
• NDC 00641606125 — Midazolam: 25 Vial In 1 Carton (0641-6061-25) / 1 Ml In 1 Vial (0641-6061-01) (159 hospitals, 1,561–3,253 samples)
• NDC 00409-7101-69 — SODIUM CHLORIDE 0.9 % IV SOLN (ADD-VANTAGE) (27 hospitals, 2,712–3,252 samples)
• NDC 00143-9595-25 — LIDOCAINE HCL (81 hospitals, 2,450–3,251 samples)
• NDC 63323-0064-11 — MAGNESIUM SULFATE 500 MG/ML (50 %) INJ SOLN (103 hospitals, 2,781–3,249 samples)
• NDC 00074-7531-31 — IOPAMID 300MG/ML 150MLINJ (5 hospitals, 3,114–3,249 samples)
• NDC 169633910 — NovoLOG FlexPen (107 hospitals, 3,159–3,249 samples)
• NDC 63323046631 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (84 hospitals, 2,051–3,248 samples)
• NDC 42799081501 — PREDNISOLONE SODIUM PHOSPHATE 15 MG/5 ML (3 MG/ML) ORAL SOLUTION (126 hospitals, 890–3,248 samples)
• NDC 00032004670 — LIPASE-PROTEASE-AMYLASE (PORK)6,000-19,000-30,000 UNIT CAPSULE,DEL REL (137 hospitals, 3,121–3,247 samples)
• NDC 00597015337 — EMPAGLIFLOZIN 25 MG TABLET (119 hospitals, 3,147–3,246 samples)
• NDC 63323-0162-26 — KETOROLAC 60 MG/2 ML INTRAMUSCULAR SOLUTION (25 hospitals, 3,190–3,244 samples)
• NDC 58468013001 — sevelamer carbonate 800 mg Tab (171 hospitals, 3,196–3,241 samples)
• NDC 55111078948 — SEVELAMER CARBONATE 800 MG TABLET (47 hospitals, 3,196–3,241 samples)
• NDC 68094003464 — sevelamer carbonate 800 mg tab (86 hospitals, 3,196–3,241 samples)
• NDC 55111078911 — SEVELAMER CARBONATE 800 MG TABLET (19 hospitals, 3,196–3,241 samples)
• NDC 00781-3289-91 — CLINDAMYCIN 600 MG/50 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK (98 hospitals, 3,204–3,240 samples)
• NDC 71288072352 — BUPIVACAINE HCL 0.25 % IJ SOLN (48 hospitals, 2,023–3,238 samples)
• NDC 43386068001 — PENTAZOCINE 50 MG-NALOXONE 0.5 MG TABLET (46 hospitals, 3,120–3,237 samples)
• NDC 65862092127 — 65862-0921-27 - sevelamer 800 mg / 1 tab(s) Tab (184 hospitals, 3,120–3,237 samples)
• NDC 00121155010 — CODEINE 10 MG-GUAIFENESIN 100 MG/5 ML ORAL LIQUID (79 hospitals, 3,120–3,237 samples)
• NDC 24338026010 — Nymalize (143 hospitals, 3,120–3,237 samples)
• NDC 00904711906 — Calcium Acetate: 50 Blister Pack In 1 Carton (0904-7119-06) / 1 Capsule In 1 Blister Pack (135 hospitals, 3,120–3,237 samples)
• NDC 58468013201 — SEVELAMER CARBONATE 0.8 G PO PACK (146 hospitals, 3,120–3,237 samples)
• NDC 50268072011 — SEVELAMER CARBONATE 800 MG TABLET (133 hospitals, 3,120–3,237 samples)
• NDC 00469-0520-02 — Isavuconazonium sulfate 186 mg *NF* (120 hospitals, 3,190–3,235 samples)
• NDC 43598-0394-67 — TETRABENAZINE 12.5 MG PO TABS (41 hospitals, 3,190–3,235 samples)
• NDC 64764-0800-28 — PRESCRIPTION DRUG, ORAL, NON CHEMOTHERAPEUTIC, NOS (29 hospitals, 3,190–3,235 samples)
• NDC 68094-0043-62 — SUCRALFATE 100 MG/ML ORAL SUSPENSION (30 hospitals, 3,190–3,235 samples)
• NDC 00078-0698-99 — Midostaurin 25 mg capsule (41 hospitals, 3,190–3,235 samples)
• NDC 54482-0054-01 — procarbazine 50 mg cap (31 hospitals, 3,190–3,235 samples)
• NDC 58181-3041-05 — lomustine 40 mg Cap (45 hospitals, 3,190–3,235 samples)
• NDC 68462-0446-26 — SEVELAMER HCL 400 MG PO TABS (23 hospitals, 3,190–3,235 samples)
• NDC 50881-0025-60 — RUXOLITINIB 25 MG TABLET (4 hospitals, 3,190–3,235 samples)
• NDC 59572-0425-21 — LENALIDOMIDE 25 MG ORAL CAP (13 hospitals, 3,190–3,235 samples)
• NDC 00832-5324-11 — POTASSIUM CHLORIDE TAB-ER 10 MEQ (27 hospitals, 3,190–3,235 samples)
• NDC 59651-0723-01 — CLONAZEPAM 1 MG TABLET (7 hospitals, 3,190–3,235 samples)
• NDC 59651-0780-30 — GLIPIZIDE ER 2.5 MG TABLET, EXTENDED RELEASE 24 HR (6 hospitals, 3,190–3,235 samples)
• NDC 62559-0421-01 — HYOSCYAMINE SULFATE 0.125 MG TABLET (3 hospitals, 3,190–3,235 samples)
• NDC 68382-0093-01 — CARVEDILOL 6.25 MG ORAL TAB (20 hospitals, 3,190–3,235 samples)
• NDC 66993-0235-60 — DASATINIB 70 MG TABLET (8 hospitals, 3,190–3,235 samples)
• NDC 55513-0488-40 — TRABECTEDIN 1 MG INTRAVENOUS SOLUTION (4 hospitals, 3,190–3,235 samples)
• NDC 00078-0651-06 — ELVITEG 150 MG-COB 150 MG-EMTRICIT 200 MG-TENOFO DISOPRO 300 MG TABLET (2 hospitals, 3,190–3,235 samples)
• NDC 51079-0455-20 — SIMVASTATIN 20 MG ORAL TAB (5 hospitals, 3,190–3,235 samples)
• NDC 72579-0011-02 — BRUKINSA 80 MG CAPSULE (5 hospitals, 3,190–3,235 samples)
• NDC 00054-0249-13 — IMATINIB MESYLATE 400 MG TAB (4 hospitals, 3,190–3,235 samples)